Evidence for the Role of Epstein Barr Virus Infections in the Pathogenesis of Acute Coronary Events

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Binkley, Philip F ^a,b   Cooke, Glen E ^a,b   Lesinski, Amanda ^a   Taylor, Mackenzie ^b   Chen, Min ^a   Laskowski, Bryon ^a   Waldman, W James ^a   Ariza, Maria E ^a   Williams, Marshall V ^a   Knight, Deborah A ^a   Glaser, Ronald ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; VIRUS PROTEIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME SYNTHESIS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; VIRUS REACTIVATION;

EID: 84872548132     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054008     Document Type: Article

References (44)

1. Glaser R, Pearson GR, Jones JF, Hillhouse J, Kennedy S, et al. (1991) Stress-related activation of epstein-barr virus. Brain Behav Immun 5 (2) (): 219-232.
2. Glaser R, Padgett DA, Litsky ML, Baiocchi RA, Yang EV, et al. (2005) Stress-associated changes in the steady-state expression of latent epstein-barr virus: Implications for chronic fatigue syndrome and cancer. Brain Behav Immun 19 (2) (): 91-103.
3. Horvath R, Cerny J, Benedik J Jr, Hokl J, Jelinkova I, et al. (2000) The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol 16 (1) (): 17-24.
4. Danesh J, Appleby P, (1998) Persistent infection and vascular disease: A systematic review. Expert Opin Investig Drugs 7 (5) (): 691-713.
5. Ibrahim AI, Obeid MT, Jouma MJ, Moasis GA, Al-Richane WL, et al. (2005) Detection of herpes simplex virus, cytomegalovirus and epstein-barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J Clin Virol 32 (1) (): 29-32.
6. Gattone M, Iacoviello L, Colombo M, Castelnuovo AD, Soffiantino F, et al. (2001) Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age. Am Heart J 142 (4) (): 633-640.
7. Morre SA, Stooker W, Lagrand WK, van den Brule AJ, Niessen HW, (2000) Microorganisms in the aetiology of atherosclerosis. J Clin Pathol 53 (9) (): 647-654.
8. Stassen FR, Vainas T, Bruggeman CA, (2008) Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol Rep 60 (1) (): 85-92.
9. Stassen FR, Vega-Cordova X, Vliegen I, Bruggeman CA, (2006) Immune activation following cytomegalovirus infection: More important than direct viral effects in cardiovascular disease? J Clin Virol 35 (3) (): 349-353.
10. Vliegen I, Herngreen SB, Grauls GE, Bruggeman CA, Stassen FR, (2005) Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice. Atherosclerosis 181 (1) (): 39-44.
11. Lippi G, Franchini M, Favaloro EJ, (2010) Influenza and cardiovascular disease: Does swine-origin, 2009 H1N1 flu virus represent a risk factor, an acute trigger, or both? Semin Thromb Hemost 36 (1) (): 49-58.
12. Phrommintikul A, Kuanprasert S, Wongcharoen W, Kanjanavanit R, Chaiwarith R, et al. (2011) Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 32 (14) (): 1730-1735.
13. Warren-Gash C, Smeeth L, Hayward AC, (2009) Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review. Lancet Infectious Diseases 9 (10) (): 601-610.
14. Guan XR, Li X, Xin XM, Jiang LX, Cui LY, et al. (2008) Influenza virus infection and risk of acute myocardial infarction. Inflammation 31 (4) (): 266-272.
15. Dvorakova A, Poledne R, (2004) Influenza-a trigger for acute myocardial infarction. Atherosclerosis 172 (2) (): 391.
16. Pretet JL, Mercier M, Riethmuller D, Aubin F, Vuitton D, et al. (2012) Human papillomavirus and cardiovascular disease. J Am Coll Cardiol 60 (1) (): 81-82.
17. Waldman WJ, Williams MV Jr, Lemeshow S, Binkley P, Guttridge D, et al. (2008) Epstein-barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: Evidence for depression-induced atherosclerotic risk. Brain Behav Immun 22 (2) (): 215-223.
18. Libby P, Ridker PM, Maseri A, (2002) Inflammation and atherosclerosis. Circulation 105 (9) (): 1135-1143.
19. Ross R, (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340 (2) (): 115-126.
20. Fuster V, Badimon L, Badimon JJ, Chesebro JH, (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 326 (5) (): 310-318.
21. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, et al. (2008) Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Med 5 (4) (): e78.
22. Fisman EZ, Benderly M, Esper RJ, Behar S, Boyko V, et al. (2006) Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol 98 (1) (): 14-18.
23. Lindmark E, Diderholm E, Wallentin L, Siegbahn A, (2001) Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: Effects of an early invasive or noninvasive strategy. JAMA 286 (17) (): 2107-2113.
24. Lee KW, Blann AD, Lip GY, (2005) Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes. Thromb Haemost 94 (5) (): 1077-1083.
25. Printseva OY, Peclo MM, Gown AM, (1992) Various cell types in human atherosclerotic lesions express ICAM-1. further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol 140 (4) (): 889-896.
26. Empana JP, Canoui-Poitrine F, Luc G, Juhan-Vague I, Morange P, et al. (2008) Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: The PRIME study. Eur Heart J 29 (16) (): 1966-1974.
27. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, et al. (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The atherosclerosis risk in communities (ARIC) study. Circulation 96 (12) (): 4219-4225.
28. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J, (1998) Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351 (9096) (): 88-92.
29. Haim M, Tanne D, Boyko V, Reshef T, Goldbourt U, et al. (2002) Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. data from the bezafibrate infarction prevention (BIP) study. J Am Coll Cardiol 39 (7) (): 1133-1138.
30. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, et al. (2001) Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104 (12) (): 1336-1342.
31. Glaser R, Litsky ML, Padgett DA, Baiocchi RA, Yang EV, et al. (2006) EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease. Virology 346 (1) (): 205-218.
32. Ariza ME, Glaser R, Kaumaya PT, Jones C, Williams MV, (2009) The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway. J Immunol 182 (2) (): 851-859.
33. Williams MV, Parris DS, (1987) Characterization of a herpes simplex virus type 2 deoxyuridine triphosphate nucleotidohydrolase and mapping of a gene conferring type specificity for the enzyme. Virology 156 (2) (): 282-292.
34. Williams MV, Holliday J, Glaser R, (1985) Induction of a deoxyuridine triphosphate nucleotidohydrolase activity in epstein-barr virus-infected cells. Virology 142 (2) (): 326-333.
35. Jones JF, Williams M, Schooley RT, Robinson C, Glaser R, (1988) Antibodies to epstein-barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome. Arch Intern Med 148 (9) (): 1957-1960.
36. Padgett DA, Hotchkiss AK, Pyter LM, Nelson RJ, Yang E, et al. (2004) Epstein-barr virus-encoded dUTPase modulates immune function and induces sickness behavior in mice. J Med Virol 74 (3) (): 442-448.
37. Lee KW, Lip GY, Tayebjee M, Foster W, Blann AD, (2005) Circulating endothelial cells, von willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 105 (2) (): 526-532.
38. Postadzhiyan AS, Tzontcheva AV, Kehayov I, Finkov B, (2008) Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Clin Biochem 41 (3) (): 126-133.
39. Rohde LE, Hennekens CH, Ridker PM, (1999) Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. Arterioscler Thromb Vasc Biol 19 (7) (): 1595-1599.
40. Kiecolt-Glaser JK, Dura JR, Speicher CE, Trask OJ, Glaser R, (1991) Spousal caregivers of dementia victims: Longitudinal changes in immunity and health. Psychosom Med 53 (4) (): 345-362.
41. Dimsdale JE, (2008) Psychological stress and cardiovascular disease. J Am Coll Cardiol 51 (13) (): 1237-1246.
42. Bhattacharyya MR, Steptoe A, (2007) Emotional triggers of acute coronary syndromes: Strength of evidence, biological processes, and clinical implications. Prog Cardiovasc Dis 49 (5) (): 353-365.
43. Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L, (2005) The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: The emerging field of behavioral cardiology. J Am Coll Cardiol 45 (5) (): 637-651.
44. Emani S, Binkley PF, (2010) Mind-body medicine in chronic heart failure: A translational science challenge. Circ Heart Fail 3 (6) (): 715-725.